Anamaria Grigore

Senior marketing leader in MedTech, Diagnostics and Life Sciences

I join your team to shape marketing strategy and steer execution from concept to global launch — turning market insights into faster adoption, competitive wins, and market share and profitability growth.

+$80–120M
revenue influenced
+15–30%
margin gain
30–50% faster
adoption cycles
+50%
New accounts & retention
100%
best CX

I don’t pretend to know it all. Curiosity, self-awareness, and the ability to learn fast define how I lead. I know where I shine and where to lean on experts, and I see that as the foundation of good leadership.

Skills can be taught; curiosity and humility can’t — and they are what enable me to adapt, grow, and turn expertise into measurable outcomes.

2003–2005
M.Sc. Biophysics & Medical Physics
2005–2008
Research Fellow
2008–2014
Product Manager — Laboratory Equipment
2014–2020
Strategic Marketing Manager — Histopathology & Cancer Diagnostics
2020–2022
Global Marketing Manager — Pharma Environmental Monitoring
2022–Present
Global Marketing Director — Clinical Microbiology Laboratory Automation

What I bring

  • Market clarity that accelerates adoption: by uncovering unmet needs, mapping customer journeys and aligning evidence with policy.
  • Strategic fit that secures growth: from product concept to global launch to deliver profitable adoption and increased market share.
  • Faster adoption & clear demonstrated value, including TCO and ROI for clinicians, lab managers, procurement and C-suite that shorten time-to-value and prevent stalls.
  • Price & margin discipline: value-based corridors and deal so growth doesn’t erode GP.
  • Competitive conversion & value offer: evidence-based messaging (clinical, operational, financial) that win head-to-head evaluations and public tenders.
  • Commercial strategy development, execution and adaptation across the innovation adoption life cycle: from opportunity identification, sharp value propositions and content distribution that moves opportunities in and through the funnel.

Why I Am Different

  • Bridge between science and business — trained as a scientist, built a career in marketing. Able to speak the language of researchers and regulators while translating it into strategies that resonate with executives.
  • Evolved with the practice of marketing — grew from an era of selling products and technical features to shaping value propositions, building impact-driven strategies, and enabling customer partnerships, trust, and long-term value for both the business and its customers.
  • Proven in conservative markets — track record of driving adoption in industries where regulations are strict and customers are cautious, from digital pathology to pharma QC.
  • Customer-first mindset — skilled at uncovering unmet needs and turning them into portfolio direction, commercial tools, and product launches that drive adoption.
  • Global view with local impact — 15+ years across EMEA, the US, LATAM, and Asia, ensuring strategies land with sales teams and customers in the field.

Experience across four markets

Molecular biology / incubation / cryopreservation

Molecular biology, incubation, cryopreservation

Built market access in highly cost-sensitive, tender-driven environments. Developed value cases that balanced technical performance with financial realities, enabling adoption where budgets were restrictive. Gained first-hand experience of distributor dynamics, navigating procurement processes, and strengthening customer trust through tailored solutions and after-sales support.

Histopathology and digital pathology

Histopathology & digital pathology

Supported the transformation of pathology from manual workflows to digital and automated solutions. Overcame early scepticism by framing clear workflows and use cases, showing how automation could improve efficiency and reliability. Enabled laboratories to take first steps toward digital adoption, while also driving confidence in automated systems that laid the foundation for scalable, future-ready pathology practices.

Pharma microbiology / environmental monitoring

Pharma microbiology automation (environmental monitoring)

Laid the commercial foundation for BD’s entry into the pharma quality control space — a highly regulated but strategically attractive market. Built the first global strategy for automation by sizing opportunities, analysing competitor moves, and aligning with Annex 1 and FDA requirements. Partnered with top pharma manufacturers and CMOs to uncover unmet needs, turning their insights into business cases that shaped BD’s investment decisions and opened the door to a new recurring revenue stream.

Clinical microbiology automation

Clinical microbiology automation

Deliver global commercial impact for the market-leading automation portfolio. Influence financial decisions by shaping portfolio investment priorities, defining value-based pricing, and aligning commercial strategy to revenue optimisation. Partner with R&D and regions to lead end-to-end innovation launches — turning VOC and customer feedback into products, messaging, and tools that sustain a healthy funnel, accelerate adoption, and protect profitability.

Let’s Discuss Impact

Curiosity, Creativity, and Clarity — that’s how I create value.

Download my resume